Navigation Links
Novogen Announces Presentation at Rodman & Renshaw 16th Annual Healthcare Conference
Date:9/3/2014

SYDNEY, Sept. 3, 2014 /PRNewswire/ -- Novogen Ltd. (ASX: NRT, NASDAQ: NVGN) today announced that Graham Kelly PhD, CEO, will present at the Rodman & Renshaw 16th Annual Healthcare Conference on Wednesday, September 10th in New York.  Dr. Kelly will provide an overview of the two Novogen first-in-class drug technology platforms in the field of oncology.  His presentation will take place at the New York Palace Hotel and will begin at 10:25am.

About Novogen LimitedNovogen is a public, Australian drug-development company whose shares trade on both the Australian Securities Exchange ('NRT') and NASDAQ ('NVGN'). The Novogen Group includes a New Haven CT-based joint venture company, CanTx Inc, with Yale University.

Novogen has two main drug technology platforms: super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). SBP compounds have been created to kill the full range of cells within a tumor, but particularly the cancer stem cells. The ATM compounds target the microfilament component of the cancer cell and when used in conjunction with standard anti-microtubular drugs, result in comprehensive and fatal destruction of the cancer cell's cytoskeleton. Ovarian cancer, colorectal cancer, malignant ascites, prostate cancer, neural cancers (glioblastoma, neuroblastoma) and melanoma are the key clinical indications being pursued, with the ultimate objective of employing both technologies as a unified approach to first-line therapy.

Further information is available on the Company's website, www.novogen.com.

For more information please contact:Corporate ContactMedia enquiriesExecutive Chairman & CEO
Novogen Group
Graham.Kelly@novogen.com 
+61 (0) 2 9472 4100In the USA:Lazar Partners
Novogen@lazarpartners.com 
+1 212-867-1762Investors enquiriesIn Australia:In the USA:Lazar Partners

Novogen@lazarpartners.com

+1 212-867-1762

Dr. Douglas Pretsell

Instinctif Partners

+61 (0) 3 9657 0706In ROW:Sue Charles

Instinctif Partners

+44 (0) 20 7457 2020Logo - http://photos.prnewswire.com/prnh/20131220/NY36990LOGO 


'/>"/>
SOURCE Novogen Ltd.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Novogen Announces Results of General Meeting of Shareholders
2. Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy
3. Top Active Companies to Watch: Crown Marketing, Herbalife, Novogen, GNC, Pfizer and Infinity Pharmaceuticals
4. Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
5. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
6. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
7. Ascendant Solutions, Inc. Announces Completion of Second Pharmacy Acquisition by Its Doughertys Holdings Subsidiary
8. Integrity Applications, Inc. Announces Equity Financing of $3.0 Million
9. GenSpera Announces Generic Name "Mipsagargin" for Lead Drug Candidate G-202 per Recommendation by World Health Organization
10. Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections
11. MarketResearch.com Announces Addition of New Kalorama Information Content to Diagnostics Knowledge Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
Breaking Medicine News(10 mins):